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Conclusions. The present study demonstrates that the ex-Cell surface heparan sulfate proteoglycans control the response
pression of cell surface HSPG was essential for the proliferationof renal interstitial fibroblasts to fibroblast growth factor-2.
of renal fibroblasts in response to FGF-2, and therefore mayBackground. While the progression of renal disease to end
play a major role in the development and persistence of astage is strongly correlated with tubulointerstitial changes, the
proliferating phenotype during interstitial nephritis.control of the fibrotic process within the interstitium is poorly
understood. Basic fibroblast growth factor (FGF-2) has been
implicated as a major growth factor involved in fibroblast acti-
vation and extracellular matrix synthesis. Furthermore, in many
Although glomerular and interstitial inflammation arecells, the activity of FGF-2 is controlled by a low-affinity but
hallmarks of progressive renal disease [1], the eventshigh-capacity interaction with heparan sulfate (HS) proteogly-
cans (PGs), such as members of the syndecan family. These determining whether the initial insult progresses to end-
molecules are likely to be central to the control of interstitial stage renal failure are poorly understood. What is clear,
fibrosis, but as yet, there has been no characterization of their however, is that in many instances, the decline in renalsynthesis by interstitial cells.
function is more closely linked to interstitial extracellularMethods. The expression of HSPG on the surface of NRK
matrix accumulation and expansion than to changes in49F fibroblasts was demonstrated by immunohistochemistry
and by metabolic labeling with [35S]-sulfate. HSs were charac- the glomerulus [2, 3].
terized by specific enzymatic digestion, size exclusion chroma- Fibrosis in other organs is considered the direct result
tography, and anion exchange chromatography. The mRNA
of fibroblast activation, and there is a well-describedfor syndecan 1 through syndecan 4 in the fibroblasts was de-
sequence of matrix protein deposition that occurs duringtected by semiquantitative reverse transcription-polymerase
chain reaction. Fibroblast proliferation was measured by the fibrotic progression. In the cortical interstitium of the
MTT assay. kidney, fibroblasts are thought to play a major role in
Results. Immunohistochemistry and [35S]-sulfate-labeling dem- matrix deposition and hence represent an important cell,
onstrated that renal fibroblasts expressed HSPGs on their sur-
dictating whether or not the insulted kidney proceedsface. Furthermore, enzymatic removal of these HS (but not
to renal failure [4–11]. The synthesis, deposition, andchondroitin sulfate) glycosaminoglycan (GAG) chains, or inhi-
bition of GAG sulfation, abolished the proliferative response turnover of matrix components by fibroblasts are con-
of both NRK cells and primary human cortical fibroblasts to trolled by soluble mediators and growth factors such as
FGF-2 but not to platelet-derived growth factor. The addition transforming growth factor-b (TGF-b) and basic fibro-
of conditioned medium, containing HS-GAG fragments, re-
blast growth factor (FGF-2). Furthermore, in many cells,stored the proliferative response to FGF-2, confirming the spec-
the biological effect of these mediators is modulated byificity of the interaction. Finally, the mRNA for all four synde-
cans was detected in the fibroblasts, and that for syndecan 1 their interaction with matrix- and cell-associated proteo-
in particular was up-regulated by FGF-2. glycans (PGs) [12–15].
Proteoglycans are specialized glycoproteins with a
protein core, which is covalently substituted with a com-
Key words: fibrosis, interstitial inflammation, syndecan family, cell pro-
plex pattern of glycosaminoglycan (GAG) side chains.liferation, progressive renal disease, extracellular matrix, prosteo-
glycans. These GAG chains confer a strong anionic charge, and
in the kidney their principal role is to provide the charge
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ionic barrier, which is principally provided by the hep- well plates and cultured in 5% FCS for 24 hours to
subconfluence. Cells were then incubated under the ap-aran sulfate (HS) PGs agrin and perlecan, leads to a
loss of filter function and to proteinuria [16–19]. Other propriate experimental conditions. At the end of each
incubation, the medium was removed, and for analysisHSPGs, such as glypican, CD44, and members of the
syndecan family of transmembrane PGs [20–24], are ex- by MTT assay, 100 mL of MTT (Sigma, Poole, UK; 1.25
mg/mL in DMEM/Ham’s medium) were added to thepressed on the cell surface and, in some cells, serve as
low-affinity binding sites for several different heparin- monolayers. The cells were incubated at 378C for four
hours. The formazan precipitate formed was solubilizedbinding growth factors, including FGF-2 [25]. The bind-
ing of growth factors to the GAG component of these by incubation with 20% sodium dodecyl sulfate (SDS)
and 50% dimethyl formamide overnight, and the ab-molecules is a prerequisite for the increased local con-
centration of the factor, its stability, conformation, and sorbance was determined at 600 nm. The lower limit of
sensitivity of the MTT assay was established as equiva-subsequent transfer to specific, high-affinity signaling re-
ceptors [24]. lent to 880 6 79 cells with a correlation coefficient of
0.95 between cell number and absorbance at 600 nm.The clinical significance of the expression of particular
HS-GAG structures was demonstrated by Morita et al, For cell counting, at the end of each incubation, the
medium was removed, and cells were released from eachwho examined the expression of HS-GAG chains in re-
nal biopsy sections [26]. While total HS expression was well by incubation with 0.05% trypsin/0.02% ethylenedi-
aminetetraacetic acid (EDTA) in calcium- and magne-increased in both the glomerulus and the tubulointerstit-
ium, FGF-2 binding was only increased on cells in the sium-free phosphate-buffered saline (PBS), pH 7.3. Cells
were then counted in a hemocytometer.interstitium, suggesting that the expression of specific
cell surface HSPG may play a major role in controlling The conditions needed to maintain the fibroblasts in
stable growth-arrested conditions were established byfibrotic events in the interstitium. This again emphasizes
the potential importance of the interstitial fibroblast in seeding cells onto 96-well plates and incubating them in
5% FCS for 24 hours. The cells were then exposed tofibrotic progression. Despite great interest in recent
years in characterizing the renal interstitial fibroblast and fresh medium containing either 0 to 5% FCS or 0 to 1%
lactalbumin hydrolysate (LH) for up to 72 hours, andunderstanding its function, however, the metabolism and
turnover of growth factor-binding PGs by this cell have the cell numbers were estimated at 24-hour intervals by
MTT assay. Serum concentrations of 1% FCS or highernot been examined. The present report examines the
expression of cell surface HSPGs by renal interstitial were proliferative, while at concentrations of 0.1% or
below, cells lost viability. At 0.5% FCS, or at 0.2% LH,fibroblasts and addresses their importance for the re-
sponse of the cell to FGF-2. the cells became quiescent and remained viable through-
out the culture periods tested up to 120 hours (data not
shown).
METHODS
In all subsequent experiments to evaluate fibroblast
Cell culture proliferation, cells were growth arrested for 72 hours
before treatment or stimulation. In proliferation experi-Renal fibroblasts (NRK49F) were purchased from the
European Collection of Animal Cell Cultures (ECACC ments, quiescent fibroblasts were incubated either in se-
rum-free medium, supplemented with 0.2% lactalbuminNumber 86101301; Center for Applied Microbiology &
Research, Salisbury, Wiltshire, UK). Human cortical fi- (negative control), 5% FCS (positive control), or serum-
free medium containing FGF-2 or platelet-derived growthbroblasts were prepared from normal tissue obtained at
nephrectomy as described previously [8]. The cells were factor (PDGF)-BB (R&D Systems Europe Ltd., Abing-
don, Oxford, UK).maintained in Dulbecco’s modified Eagle’s medium
(DMEM)/Ham’s F-12 containing, 2 mmol/L l-glutamine,
Metabolic labeling of proteoglycans100 U/mL of penicillin, and streptomycin, and they were
supplemented with 5% fetal calf serum (FCS; Hyclone, We have previously described the metabolic labeling
of renal cells with [35S]-sulfate [28, 29] and in the currentErembodegem-Aalst, Belgium) at 378C in a humidified
incubator in an atmosphere of 5% CO2. All tissue culture report this was the same with the exception that the
medium was based on DMEM/Ham’s F12. At conflu-reagents were obtained from GIBCO/BRL Life Tech-
nologies (Paisley, UK). ence, the growth medium was removed. The cells washed
three times with PBS, and the cells were growth arrested
Estimation of cell numbers by maintenance in 0.2% LH in DMEM/Ham’s-F12 for 48
hours. The cells were washed with PBS and metabolicallyBoth direct cell counting and the 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay labeled with 50 mCi/mL carrier-free [35S]-sulfate in
DMEM/Ham’s-F12, containing 10% of the normal sul-were used to determine renal fibroblast cell numbers
[27]. The cells were seeded at 5 3 103 cells/well in 96- fate concentration and supplemented with either 5%
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sulfate-depleted FCS (prepared by exhaustive dialysis nases I, II, and III (Grampian Enzymes, Orkney, UK)
or chondroitin ABC lyase (50 mU; ICN, Basingstoke,against low sulfate DMEM-Ham’s F12) or 0.2% lactalbu-
min for 24 hours, to attain a steady-state equilibrium UK) as a control for up to 48 hours. The cells were then
incubated either in serum-free medium, supplementedbetween synthesis and the combined pathways of secre-
tion and digestion. with 0.2% lactalbumin (negative control), 5% FCS (posi-
tive control), or in serum-free medium containing FGF-2
Analysis of cell surface proteoglycans or PDGF-BB for the appropriate times. The fibroblasts
were then washed in PBS and fixed for immunocyto-After labeling with [35S]-sulfate, the culture medium
was collected. The cells were washed three times with chemistry, or cell numbers were estimated by MTT assay,
as described previously in this article.PBS, and the cell surface PGs were released by incuba-
tion with 20 mg/mL trypsin in PBS on ice for five minutes.
Inhibition of HSPG sulfationThis treatment has been shown previously to release cell
surface PGs without affecting cell viability [30, 31]. The Sodium chlorate was used to inhibit sulfate adenyl-
transferase activity and thus prevent sulfate donation totrypsin-inaccessible material remaining in the intact cell
layer was extracted with 4 mol/L urea in Tris-Bis buffer, newly synthesized GAG chains [32]. Renal fibroblasts
were growth arrested for 72 hours in sulfate-free DMEMpH 6.0, containing 0.1% CHAPS. The trypsin-released
and trypsin-resistant materials were then separately passed (GIBCO-BRL) containing 0.5% sulfate-depleted FCS.
The medium was then removed, and the cells were incu-over a column of DEAE Sephacel, equilibrated with 4
mol/L urea in Tris-Bis buffer, pH 6.0, containing 0.1% bated in fresh sulfate-free DMEM and 0.5% sulfate-
depleted FCS, containing sodium chlorate (0 to 30 mmol/L)CHAPS [28, 29]. The column was washed with 0.3 mol/L
NaCl in the urea buffer, and the bound [35S]-labeled PGs for 48 hours. The absence of sulfated cell surface GAG
was confirmed by immunohistochemical staining withwere eluted with 1.5 NaCl in urea buffer. These were then
dialyzed against 50 mmol/L Tris HCl, pH 8.0, containing antibody 10E4 as described previously in this article.
Fibroblasts were then incubated in serum-free medium,50 mmol/L NaCl and incubated with 125 mU of chondroi-
tin ABC lyase at 378C. The remaining [35S]-labeled HSPGs supplemented with 0.2% lactalbumin, 5% FCS, or in
serum-free medium containing FGF-2, and cell numberswere then precipitated with three volumes of 1% wt/vol
potassium acetate in 95% ethanol in the presence of were estimated by MTT assay as described previously
in this article.50 mg/mL each of heparin and chondroitin sulfate as
coprecipitants and analyzed on Sepharose CL-4B col-
Semiquantitative RT-PCR analysis ofumns equilibrated with 4 mol/L guanidine in 50 mmol/L
fibroblast syndecanssodium acetate buffer, pH 6.0, containing 0.5% Triton
X-100 and 0.05% sodium azide. In all experiments to isolate and identify the mRNA
for specific proteins, fibroblast monolayers were estab-
Immunohistochemical identification of lished and incubated in six-well plates. At the end of the
HS-GAG chains appropriate incubation, the cells were washed once in
PBS, pH 7.3, and then lyzed by the addition of 1 mL/Fibroblasts were fixed and permeabilized in cold 50%
acetone:50% methanol (2208C) for five minutes fol- well of RNA-isolator (Genosys, Cambridge, UK). Chlo-
roform (0.1 mL) was then added, and the mixture waslowed by three washes in PBS. Nonspecific sites on the
fixed cells were blocked with 1% bovine serum albumin shaken for 30 seconds. Samples were incubated at 48C
for 5 minutes and centrifuged at 20,000 3 g for 15 min-(BSA) and 1% dried milk in PBS, and the slides were
incubated with an anti-HSPG antibody that specifically utes. The aqueous phase was then decanted and mixed
with an equal volume of isopropanol. This was incubatedrecognizes sulfated HS-GAGs (10E4-mAb, 1 in 30 dilu-
tion; AMS Biotechnology, Whitney, UK) at room tem- at 2708C for 24 hours, and the precipitate was pelleted
by centrifugation at 20,000 3 g at 48C for 20 minutes.perature for one hour. The cells were washed four times
with 1% BSA, 1% dried milk in PBS and then incubated The isolated RNA was washed twice with 500 mL of
75% ethanol, and the pellet was air dried at room tem-with the secondary antibody FITC-conjugated anti-IgM
(1:80; Sigma) at room temperature for one hour. The perature for 5 to 10 minutes. The RNA was dissolved
in 10 mL of H2O, and its concentration was calculatedcells were washed with PBS, mounted in Vectashield fluo-
rescent mountant (Vector Laboratories, Peterborough, from the absorbance at 260 nm. The integrity of the
RNA was assessed by flat-bed electrophoresis.UK), and examined on a Leica Dialux 20 fluorescent
microscope. Reverse transcription (RT) was performed using the
random hexamer method. RNA 1 mg was added to 1 mL
Enzymatic removal of HS-GAG chains of 100 mmol/L random hexamers (Pharmacia Biosys-
tems, Milton Keynes, UK), 5 mL NTP (2500 nmol mixedFibroblasts were grown to subconfluence and incu-
bated with either a cocktail of 0.3 mU each of hepariti- nucleotides: dATP, dCTP, dGTP, dTTP; GIBCO/BRL),
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Table 2. Amplification cyclesTable 1. Syndecan polymerase chain reaction (PCR) primer constructs
Gene Primer pairs Size Taq activation 22–34 cycles of Followed by
948C for 0.6 minutesSyndecan-1 39-TCCAGAACGGGTGGAACTGG-59 339bpa
59-GCAGTCTTAGTGCAACCCGG-39 958C for 10 minutes 608C for 0.6 minutes 948C for 0.6 minutes
728C for 5 minutes 728C for 1 minute 608C for 10 minutesor
39-GGAGGCACTTCTGTCATCAA-59 212bpb
59-AGCACTTCCTTCATGTCCAA-39
Syndecan-2 39-CTCTGGCTCAGGAGATTATG-59 345bpb
59-CACCAACAACAGGATGAGGA-39
Statistical analysisSyndecan-3 39-GATGAGCCAGAGGTGCAAGT-59 259bpb
59-GCCACCTACGATCACAGCTA-39 Results are expressed as means 6 SEM of N experi-
Syndecan-4 39-AGGCGAGTCGATTCGAGAGA-59 394bpb ments. The two-tailed paired Student t test was used to
59-TCAGAGCTGCCAAGACCTCA-39
compare values with controls. A value of P , 0.05 was
a-Actin 39-GGAGCAATGATCTTGATCTT-59 204bpa
considered significant.59-TCCTGAGGTACGGGTCCTTCC-39
a Primers designed in house using Lazergene primer design software
b Primer sequences obtained from published reports [33, 34]
RESULTS
Renal fibroblasts express cell-surface HSPG
To demonstrate the expression of HSPG on the sur-
2 mL 1 mmol/L Tris-HCl (pH 8.3), 500 mmol/L KCl (15 face of renal fibroblasts, cells were metabolically labeled
mmol/L MgCl2, and 0.001% wt/vol gelatin) and 2 mL of with [35S]-sulfate for 24 hours, followed by a brief incuba-
100 mmol/L dithiothreitol. The solution was heated to tion with trypsin to release cell surface PGs. This treat-
ment released the radiolabeled macromolecules from the958C for five minutes followed by 48C for two minutes.
cell surface without causing detachment of the cells. TheOne microliter Ribonuclease inhibitor (RNAsin; Pro-
radiolabeled molecules that remained associated withmega, Southampton, UK) and 1 mL of Maloney monkey
the cells (trypsin-inaccessible) were then extracted asleukemia virus (M-MLVe) Superscript (RNase H-re-
described. Both batches of labeled material were thenverse transcriptase; GIBCO/BRL) were added to each
applied separately to DEAE-Sephacel to bind the PGssample and incubated at 228C for 10 minutes, 428C for
and allow the removal of other labeled proteins, and both60 minutes, and then 958C for five-minute cycles on a
were characterized (following removal of chondroitin/Perkin Elmer Cetus DNA thermal cycler 480. The cDNA
dermatan sulfates by digestion with chondroitin ABCproducts were stored at 2208C.
lyase) on a Sepharose CL-4B column. Analysis of the
The polymerase chain reaction (PCR) was carried out trypsin-released material indicated a single peak of ra-
in 50 mL (final volume) of 10 mmol/L Tris-HCl buffer, dioactivity, which eluted with a Kav of 0.45 (Fig. 1A).
pH 8.3, containing 50 mmol/L KCl, 1.5 mmol/L MgCl2, Further incubation of the labeled material with papain
200 mmol/L dNTP, 0.001% wt/vol gelatin, 0.5 mmol/L caused an increase in Kav to .0.6 (data not shown),
of each primer for the product of interest, and 1.25 U of indicating that the trypsin-released material was a PG
AmpliTaq-Gold DNA polymerase (Applied Biosystems, and not free GAG chains. The analysis of the trypsin-
Warrington, UK). The primers were designed from the inaccessible material indicated a broad distribution of
molecules indicative of both intact HSPG (Kav 0.2 to 0.4)published cDNA sequences [33, 34], using Lasergene
and HS-GAG fragments (Kav 0.7; Fig. 1B). These resultsPrimer Select software (Appligene, Chester-le Street,
indicate that the renal fibroblasts express HSPG on theUK; Table 1). Mineral oil (50 mL) was added to each
cell surface and that there is also a population of intracel-tube, and thermal cycling was carried out as shown in
lular labeled HS-GAGs, which may represent eitherTable 2. Each product was amplified in separate tubes,
newly synthesized HSPG or HS chains undergoing deg-and 10 mL were then separated on 3% agarose gels (2%
radation.Nusieve GTG agarose; Flowgen, Sittingbourne, UK; and
Further confirmation of the presence of cell surface1% Ultrapure agarose; GIBCO BRL), containing 0.5
HSPG was obtained by incubating [35S]-sulfate-labeled
mg/mL ethidium bromide at 70 V for one hour. The cells with heparitinase. The released material was puri-
products in the gels were visualized and photographed fied on DEAE-Sephacel as described previously in this
under ultraviolet light. Scanning densitometry using a article and analyzed on Sepharose CL-4B. Since hepariti-
BioRad GS 670 allowed the ratio of each product to that nase specifically digests HS-GAG chains, the broad elu-
of the actin housekeeping gene to be calculated. The tion profile obtained represented HS fragments (Kav 0.5
values were then normalized to the level of the unstimu- to 0.8) derived from cell surface HSPGs that were not
lated control (for dose response experiments) or the zero fully degraded to their constituent disaccharides (Fig. 2).
Finally, the presence of HSPG on the cell surface wastime control (for time course experiments).
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Fig. 2. Sepharose CL-4B chromatography of cell surface HS-GAG
after limited heparitinase digestion. NRK fibroblasts were metabolically
labeled with [35S]-sulfate for 24 hours. The medium was removed. The
cell layer was incubated for 30 minutes with a cocktail of heparitinases
I, II, and III at 378C, as described, and the released material was
applied to a column of Sepharose CL-4B as in Figure 1. Results are
representative of three separate experiments.
reactive HS epitopes from the cell surface (Fig. 3b).
Perinuclear foci of anti-HS staining, however, were ob-
served, suggesting that intracellular processing of HS
was still occurring. Newly synthesized HS-GAGs were
not detected at the cell surface during the course of
the experiment or following extended incubations with
heparitinase. In contrast, there was no effect of chondroi-
tin ABC lyase on the detection of these HS epitopes
(Fig. 3c). Neither heparitinase or chondroitin ABC lyase
incubations affected the adhesive properties of the cells,
their viability, or their proliferative response to FCS
(data not shown).
Fig. 1. Sepharose CL-4B chromatography of cell surface heparan sulfate
Proliferation induced by FGF-2 requires cellproteoglycans (HSPGs). NRK fibroblasts were metabolically labeled with
[35S]-sulfate for 24 hours. The medium was removed, and the cell layer surface HSPG
was incubated with 20 mg/mL trypsin on ice for five minutes. Portions
Having demonstrated the presence of cell surfaceof (A) the trypsin-released or (B) the trypsin-inaccessible material were
applied to DEAE-Sephacel. The bound [35S]-labeled material was HSPG, further experiments investigated whether they
eluted, incubated with chondroitin ABC lyase to remove CS/DS chains, were involved in the proliferative response of renal fi-and alcohol precipitated. Following reconstitution in 4 mol/L guanidine
broblasts to FGF-2. Initial experiments established thebuffer, the labeled HS material was applied to a column of Sepharose
CL-4B. Results are representative of four separate experiments. mitogenic potential of FGF-2 for the NRK and human
cortical fibroblasts. Growth-arrested cells were cultured
in 0.5 to 10 ng/mL FGF-2 for 48 hours at the end of which
period cell numbers were determined by MTT assay orconfirmed by immunostaining with monoclonal antibody
by direct cell counting. Fibroblasts were also incubated10E4 (Fig. 3a). This antibody recognizes intact, fully
with FCS (0 to 5%) or PDGF-BB (0 to 50 ng/mL) assulfated HS chains. Removal of immunoreactive HS epi-
positive controls. Under these conditions, the fibroblasttopes by specific digestion with heparitinase prior to fix-
ation and immunostaining completely removed immuno- numbers increased in response to all three mitogens in a
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Fig. 3. Immunofluorescent staining of HS-
GAG. NRK fibroblasts were grown to con-
fluence in DMEM-Ham’s F12 supplemented
with 5% FCS. The medium was removed, and
the cells were incubated with either (a) buffer
alone, (b) heparitinase, or (c) chondroitin
ABC lyase at 378C for 30 minutes. The cells
were washed free of enzyme, fixed, and
stained for HS-GAG using antibody 10E4.
Results are representative of three separate
experiments. Magnification 3250.
Table 3. Effect of heparitinase and chlorate on the proliferation ofdose-dependent manner (Fig. 4). In parallel experiments,
human cortical fibroblasts
cells were preincubated at 378C for 30 minutes with hep-
Cell proliferation % of controlaritinase prior to incubation with the growth factors.
Heparitinase ChlorateThis treatment of the cultures markedly and significantly
Untreated treated treatedinhibited the increase in cell numbers elicited by FGF-2
FGF-2 ng/mL(Fig. 4A). In contrast, the removal of HS from the cell
0 100 100 100surface had no significant effect on proliferation induced 0.1 118617 99618 104612
by either PDGF-BB (Fig. 4B) or FCS (Fig. 4C). Thus, 1.0 22669b 109634 110616
10.0 312612b 131619 121612the inhibition of proliferation caused by removal of HS-
PDGF-BB ng/mLGAGs was specific to the FGF-2 response. In further 0 100 100 100
0.5 149612 118635 198624aexperiments, the response of primary human cells to
5.0 241628b 170620a 209617bFGF-2 was also shown to depend on the presence of cell
50.0 256629b 230634b 356638b
surface HS-GAG chains (Table 3). FCS %
0 100 100 100These results suggested that the expression of the HS-
0.5 10068 99622 110610GAGs at the cell surface was essential for the response
1.0 201610b 224631b 16769b
of the fibroblasts to FGF-2. To confirm that this was 5.0 260615b 245611b 245614b
indeed the case, medium containing HS-GAG fragments, Growth-arrested human cortical fibroblasts in 96-well plates were either
treated with 0.3 U/mL each of heparitinase I, II, and III at 378C for 30 minutesreleased by heparitinase treatment as described pre-
or were placed in sulfate-free medium containing sodium chlorate (30 mmol/L;viously in this article (Fig. 2), was added to fibroblasts detailed in the Methods section) or were left untreated. They were then incubated
for 48 hours with either fetal calf serum (FCS), basic fibroblast growth factorfrom which cell surface HS-GAG had been completely
(FGF-2) or platelet-derived growth factor (PDGF)-BB at the indicated concen-
removed by heparitinase digestion. The cells were then trations. Cell numbers were determined by direct counting of cells released from
the wells of 96-well plates. The results are expressed as the mean percentage 6incubated with 10 ng/mL FGF-2 for 24 hours. Under these
SEM (N 5 3) of cells present after 48 hours in serum-free medium.
conditions, the inclusion of the cell surface-derived HS- Significant increases in cell numbers are shown as a P , 0.05, b P , 0.01.
GAG fragments served to restore the responsiveness of
the fibroblasts to FGF-2 in a concentration-dependent
manner (Fig. 5). to normal intensity, indicating that the inhibition was
competitively reversible (Fig. 6b).Proliferation induced by FGF-2 requires sulfation of
When cultured with FGF-2 under the same sulfate-the cell surface HSPG
depleted conditions for 48 hours, there was significant
3T3 fibroblasts maintained in sulfate-free medium and inhibition of the proliferative response to FGF-2 com-
incubated with sodium chlorate synthesize GAG chains pared with cells in normal medium (Table 3 and Fig.
with reduced sulfation and lose their proliferative re- 7). This effect was competitively and dose dependently
sponse to FGF-2 [35–37]. To confirm the role of HS- reversed by the addition of sodium sulfate (Fig. 7). Thus,
GAG chains and their sulfation in the interaction of the there is a requirement for intact, fully sulfated HS chains
renal fibroblast with FGF-2, NRK 49F cells or human for the renal fibroblasts to undergo a proliferative re-
fibroblasts were grown in sulfate-depleted conditions in sponse to FGF-2.
the presence of 30 mmol/L sodium chlorate. After cul-
Renal fibroblasts transcribe all four syndecan genesture for 24 hours, the cells were fixed and immunostained
with antibody 10E4 as described previously in this article. There are several cell surface HSPGs that could be
Under conditions in which sulfate incorporation had expressed by the renal fibroblasts. Those most closely
been competitively inhibited by chlorate, there was no associated with an affect on FGF-2 interactions, how-
cell surface or intracellular staining, confirming the ab- ever, are those of the syndecan family. RT-PCR was used
sence of sulfated HS-GAG chains (Fig. 6a). The inclu- to determine whether the cells expressed the mRNA for
any of the four syndecans. Cells were grown to 50%sion of sodium sulfate, however, restored the staining
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Fig. 5. HS-GAGs restore the response of NRK fibroblasts to FGF-2.
Cells were grown to subconfluence. The medium was removed, and the
cell layer was incubated with 0.3 U/mL heparitinase for 30 minutes.
The supernatants were collected, bulked, and heated to 808C for two
hours to inactivate the heparitinases. The HS-GAG–depleted cells were
then cultured with 10 ng/mL FGF-2 in the presence of a series of
dilutions of the HS-GAG fragments in serum-free medium for 24 hours.
Cell numbers were determined using the MTT assay. The results are
expressed as the mean percentage 6 SEM (N 5 4) of the number of
cells present after 24 hours in serum-free medium containing only 10
ng/mL FGF-2. *P , 0.05 compared with HS-GAG–depleted cells incu-
bated with FGF-2 alone.
Fig. 6. Immunofluorescent staining of sulfate-depleted fibroblasts.
Growth-arrested NRK fibroblasts were incubated in sulfate-free
DMEM containing 0.5% sulfate-free FCS and (a) 30 mmol/L sodium
chlorate or (b) 30 mmol/L sodium chlorate plus 10 mmol/L sodium
sulfate for 48 hours. The cells were then fixed and stained for cell
surface HS-GAG using antibody 10E4. Results are representative of
three separate experiments. Magnification 3250.
b
Fig. 4. Cell surface HS-GAGs are required for FGF-2–mediated cell
proliferation. Growth-arrested NRK fibroblasts were incubated in
buffer alone (h) or with 0.3 U/mL each of heparitinases I, II, and III
at 378C for 30 minutes (j). The cells were then incubated in serum-
free medium containing (a) FGF-2, (b) PDGF-BB, or (c) FCS in the
presence or absence of fresh heparitinase for 48 hours. Proliferation was
determined by MTT assay. Results are expressed as a mean percentage
increase over that of cells incubated in serum-free medium alone 6
SEM. *P , 0.05; **P , 0.01, N 5 3.
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Fig. 7. Sulfate depletion inhibits the proliferation of renal fibroblasts
in response to FGF-2. Growth-arrested NRK fibroblasts were incubated
for 48 hours with 10 ng/mL FGF-2 in sulfate-free medium containing
sodium chlorate (30 mmol/L) alone or with sodium sulfate (up to 10
mmol/L). Cell numbers were determined using the MTT assay. The
results are expressed as the mean 6 SEM (N 5 6) of the percentage
of the number of cells present after 48 hours in medium containing
only FGF-2. *P , 0.05; **P , 0.01.
Fig. 9. Basic fibroblast growth factor (FGF-2) induces syndecan 1
mRNA. Growth-arrested NRK fibroblasts were cultured with DMEM-
Ham’s F-12 supplemented with 10 ng/mL of FGF-2. At the indicated
times total RNA was extracted, and RT-PCR amplification was carried
out. The products were electrophoresed in 3% agarose containing ethid-
ium bromide, and the gel was photographed under ultraviolet light.Fig. 8. Renal fibroblasts express syndecan mRNA. Total RNA was
a-Actin was used as the housekeeping gene. The gel shown is represen-extracted from NRK 49F cells, and after RT, specific PCR was carried
tative of three separate experiments. The densitometric ratio of synde-out as described. The individual products were electrophoresed in 3%
can to actin is shown for each time point normalized to the ratio atagarose containing ethidium bromide and the gel photographed under
zero time (mean 6 SEM, N 5 3).ultraviolet light. Lane (a) base pair ladder markers, (b) syndecan 1, (c)
syndecan 2, (d) syndecan 3, (e) syndecan 4, (f) a mixture of each primer
product. The gel is representative of five separate experiments.
series of experiments. Growth-arrested fibroblasts were
stimulated with 10 ng/mL FGF-2, and RNA was ex-
confluence in 5% FCS and growth arrested in 0.5% FCS tracted at various times. RT-PCR demonstrated that ex-
for 72 hours. The total cell RNA was extracted, and RT- posure to FGF-2 triggered an immediate rise in syndecan
PCR was carried out using primers specific for syndecan 1 mRNA. This induction reached a maximum after 30
1, 2, 3, or 4 (Table 1). The PCR products were visualized minutes and returned to basal levels by 6 hours (Fig. 9).
on agarose gels. There was abundant expression of tran- During this period, there was little change in the mRNA
scripts for syndecans 2 and 4, while syndecans 1 and 3 for syndecan 2, 3, or 4 (data not shown).
were expressed to a lesser extent (Fig. 8).
FGF-2 induces syndecan-1 mRNA DISCUSSION
This report describes the identification and expressionThe possibility that FGF-2 may affect the expression
of the HSPGs, which in turn control the response of the of cell surface HSPGs on renal fibroblasts and demon-
strates that they appear essential for the control of therenal fibroblasts to FGF-2, was examined in a separate
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proliferative response of these cells to FGF-2. The pres- sity for dimerization of HS chains on the renal fibroblasts
is similar to that described in these other systems.ence of cell surface HSPGs was confirmed at several
The degree of sulfation was also a major factor control-levels. First, they could be shown, following metabolic
ling the response to FGF-2. This was shown by the uselabeling with [35S]-sulfate, to be accessible to both limited
of sodium chlorate, a competitive inhibitor of the ATP-trypsin and limited heparitinase digestion. Second, the
sulfate adenyltransferase. This enzyme participates inpresence of immunoreactive HS-GAG on the cell surface
the formation of phosphoadenosine phosphosulfate, thewas demonstrated by immunohistochemistry. Third, the
high-energy sulfate donor required by the sulfotransfer-cells were shown by RT-PCR to express the mRNA for
ases, to add sulfate groups to the newly synthesized HSeach of the four syndecan cell surface HSPGs. In addi-
chains in the Golgi. At concentrations of approximatelytion, the cell surface HSPGs were functional, and both
30 mmol/L, the transferase is inhibited, and the HStheir expression and their sulfation were essential for the
chains at the cell surface bear nonsulfated GAG chainsinitiation of a proliferative response to FGF-2. This was
[32]. Renal fibroblasts remained viable at this dose ofshown to be a mechanism that was specific for FGF-2
chlorate; however, they did not express sulfated HSsince neither proliferation in response to PDGF-BB nor
chains at the cell surface, and their proliferative responseto FCS was affected by removal of the cell surface HS
to FGF-2 was significantly impaired. The addition ofchains.
exogenous sulfate out competes chlorate, resulting inMembers of the FGF family serve diverse roles in
restoration of sulfation. This was sufficient to restore thecellular growth and differentiation during development,
proliferative effect of FGF-2 on the renal fibroblasts.in healing, and in the pathogenesis of disease [38–40].
The role of FGF in renal disease (particularly FGF-2)The cellular response to FGF is complex and in many
has been extensively examined. As well as regulating thecells is dependent not only on the expression of trans-
release of other profibrotic factors (such as TGF-b1) [50],membrane tyrosine kinase receptors [12, 41], but also
FGF-2 modulates the proliferative activity of several cellon the presence of HSPGs to facilitate FGF/receptor
types, contributing directly to renal injury and sclerosisinteraction. This is not the case, however, for all cells.
[6, 21, 51–53]. Morita et al examined the expression ofFor example, the rat thyroid cell line FRTL-5 uses a HS-
HSPG in biopsy sections of kidneys from patients withindependent mechanism for interaction with FGF-2 [42],
a variety of renal diseases [26]. Although HS-GAGs werewhile the proliferative effect of FGF-2 on other cells
observed on cells both in the glomerulus and the intersti-may be inhibited by HS chains [43]. Furthermore, not all
tium, the binding of FGF-2 was confined solely to regionscell-associated HS will bind FGF-2, and the expression of
of fibrotic injury in the interstitium. Whether this repre-specific chain structures may vary at different stages of
sents an alteration in the level of expression or a qualita-
differentiation [44–46]. The renal fibroblasts used in our
tive change in the structure of the GAG chains on cells
study, however, appear to be totally dependent on the in the interstitium is not clear.
presence of intact cell surface HS-GAG chains for the Previous emphasis in the study of fibrogenesis has
mediation of their response to FGF-2. been on the identification of particular growth factors,
Studies by Rapraeger et al have demonstrated the such as FGF, involved in modulating fibroblast behavior.
restoration of the response of cells to FGF-2 following An investigation of the interaction between these growth
the addition of heparin [47]. This raised the possibility factors, their receptors, and growth factor-binding mole-
that native GAG chains derived from the surface of renal cules such as HSPGs is essential for increasing our under-
fibroblasts may also be able to perform this function. standing of fibrotic mechanisms. Alterations in the struc-
The importance of these chains was confirmed in experi- ture, charge, or size of HSPG molecules by fibroblasts
ments in which HS-GAG fragments, obtained by limited in areas of fibrosis is a distinct possibility [26, 54], and
heparitinase digestion, were added to cells from which such changes leading to increased growth factor binding
HS had been removed. Under these conditions, the inhi- may lead to an inappropriately enhanced response to
bition of the proliferative response to FGF-2 was over- growth factors. In culture, fibroblasts isolated from fi-
come. Thus, the endoglycosidase heparitinase had re- brotic kidneys and cultured in the presence of serum
leased HS fragments, which promoted the interaction of have been described as hyperproliferative compared
FGF-2 with its signaling receptors. Structural evidence with their nonfibrotic counterparts [55, 56]. An increased
has demonstrated that an FGF-heparin complex will me- HSPG-mediated growth factor binding may explain the
diate the dimerization of receptors, resulting in receptor apparent hyperproliferative phenotype of fibroblasts de-
activation and intracellular signaling. In an analogous rived from areas of fibrosis. Furthermore, the observa-
manner, members of the cell surface HSPG syndecan tion that FGF-2 induced the transcription of de novo
family are also believed to bind FGF-2 and facilitate syndecan 1 mRNA suggests that there may be a potent
receptor dimerization and activation [48, 49]. It remains positive feedback loop that would be expected to amplify
the fibrotic response. In this respect, the renal fibroblaststo be determined whether the configuration and propen-
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